remain.fit · Insulin, Glucose and Fasting: What Changes, and When

Insulin sensitivity improves on fasting schedules mostly because of weight loss. One crossover trial in eight men with prediabetes found better insulin sensitivity, beta-cell response and blood pressure with no weight change. In type 2 diabetes, fasting two days a week lowered HbA1c about as much as daily calorie restriction over 12 months. Anyone on insulin or sulfonylureas needs supervision.

What we know, and what we don’t

We know:

Most of the insulin-sensitivity benefit tracks weight loss. In the best type 2 diabetes comparison, HbA1c fell −0.91% with an eating window and −0.94% with daily restriction, no difference between arms (Pavlou et al., 2023).
One tiny trial shows change without weight loss: 8 men, 5 weeks, intake matched so weight held (Sutton et al., 2018).
Fasting is non-inferior to daily restriction for HbA1c in type 2 diabetes (Carter et al., 2018).
Fasting raises hypoglycaemia risk in people on glucose-lowering medication, even with planned dose reduction (Corley et al., 2018: rate ratio 2.05).
Diabetes remission tracks the size of the deficit, not the schedule. DiRECT’s 46% remission at 12 months came with about 10 kg of loss on a continuous formula diet, not fasting (Lean et al., 2018).

We don’t know:

Whether the weight-loss-independent signal replicates in women, in larger samples, or beyond 5 weeks. It’s eight men.
Whether fasting changes glycaemic control more than any calorie-restricted diet once weight is matched. The trials so far say it doesn’t.
Whether the position of the window adds anything beyond the deficit. The early-window signal is small and short, and window timing covers it separately.

What does insulin sensitivity mean, plainly?

Insulin sensitivity is how readily your cells take up glucose when insulin rises. After a meal, glucose enters the blood, the pancreas releases insulin, and muscle, liver and fat tissue respond by pulling glucose in. When that response dulls, the pancreas compensates with more insulin, and glucose sits higher for longer. That dulled state is insulin resistance, and it’s the road that leads toward prediabetes and type 2 diabetes. Everything in this article is about whether changing when you eat moves that response.

Does fasting improve insulin sensitivity?

Yes, and mostly for the unexciting reason: fasting schedules help people lose weight, and weight loss improves insulin sensitivity. The interesting question is whether the schedule does anything on its own, and there the evidence is exactly one small trial. Sutton et al. (Cell Metabolism, 2018) ran a randomised crossover in men with prediabetes: a 6-hour eating window with dinner finished before 3 p.m., for 5 weeks, with food matched so nobody lost weight. In the 8 men who completed the trial (of 15 eligible), insulin sensitivity, beta-cell responsiveness, blood pressure and a marker of oxidative stress all improved. That’s a real, carefully measured signal. It’s also eight men for five weeks, and nobody has yet shown the same thing in women, in larger groups, or over longer periods.

What changes in a 10-hour eating window?

Weight, blood pressure and LDL cholesterol fell; the glucose measures didn’t reach significance. In a single-arm study of 19 adults with metabolic syndrome eating within 10 hours for 12 weeks (Wilkinson et al., Cell Metabolism, 2020), weight fell 3.3 kg, systolic blood pressure fell 5.1 mmHg and LDL fell 11.9 mg/dL. Fasting glucose (P=0.081), insulin (P=0.064), HbA1c (P=0.058) and HOMA-IR (P=0.107) all trended down without reaching significance in the whole cohort. There was no control group, so even the significant changes carry that caveat. I mention the p-values because most coverage of this study reports the trends as benefits, and they aren’t, yet.

Can intermittent fasting help with type 2 diabetes?

It can match daily calorie restriction, which is genuinely useful without being magic. Here’s the record:

Trial	Design	Result	Caveat to print
Sutton 2018, Cell Metab	8 men with prediabetes, 5-week crossover, early 6-hour window, intake matched	Insulin sensitivity, beta-cell response, blood pressure, oxidative stress improved	No weight change by design; 8 completers of 15 eligible
Wilkinson 2020, Cell Metab	19 adults with metabolic syndrome, 12 weeks, 10-hour window, single arm	Weight −3.3 kg; systolic BP −5.1 mmHg; LDL −11.9 mg/dL	Glucose, insulin and HbA1c trends not significant; no control group
Carter 2018, JAMA Netw Open	137 adults with type 2 diabetes, 12 months, 2 days/week at 500-600 kcal vs daily restriction	HbA1c −0.3% vs −0.5%, within the non-inferiority margin; weight −6.8 vs −5.0 kg	Non-inferiority design; 29% didn’t complete
Pavlou 2023, JAMA Netw Open	75 adults with type 2 diabetes and obesity, 6 months, 8-hour window with no counting vs 25% restriction vs control	HbA1c −0.91% vs −0.94%; weight −3.56% vs −1.78%	No between-arm difference on HbA1c
Corley 2018, Diabet Med	41 medicated adults with type 2 diabetes, 12 weeks, 2 fast days/week	1.4 hypoglycaemic events per person; fasting raised risk, rate ratio 2.05	Both arms fasted; the comparison was consecutive vs non-consecutive days
DiRECT 2018, Lancet	306 adults with type 2 diabetes, 12 months, total diet replacement	46% remission vs 4%; weight −10.0 vs −1.0 kg	Not a fasting trial; it anchors what deficit size achieves

Carter et al. (JAMA Network Open, 2018) is the anchor for fasting specifically: two days a week at 500-600 kcal against daily restriction for 12 months, and the HbA1c difference between groups was 0.2 percentage points, within the trial’s non-inferiority margin. Pavlou et al. (2023) found the same shape with an 8-hour window: HbA1c fell about 0.9 points in both the fasting and counting arms. If you have type 2 diabetes and prefer eating this way, the evidence says the preference is affordable. It doesn’t say the schedule adds anything.

Is hypoglycaemia a real risk?

Yes, and it’s understated almost everywhere this topic is written about. In a 12-week study of 41 adults with type 2 diabetes on glucose-lowering medication, fasting two days a week produced a mean of 1.4 hypoglycaemic events per person, and fasting raised the event rate roughly twofold (rate ratio 2.05, 95% CI 1.17 to 3.52) even though medication doses were reduced by plan beforehand (Corley et al., Diabetic Medicine, 2018). The study compared consecutive against non-consecutive fast days, so both arms fasted; the risk finding applies to the practice itself. There’s also early controlled work in insulin-treated diabetes (Obermayer et al., INTERFAST-2, Diabetes Care, 2023) reaching for the same question. The practical line is short: if your medication can cause low blood sugar, fasting changes your dosing needs, and that conversation belongs with your clinician before the first skipped meal, not after the first shaky afternoon.

Does fasting reverse type 2 diabetes?

There’s no evidence that the schedule itself does. The honest anchor for remission is DiRECT (Lean et al., Lancet, 2018): 306 adults, and 46% of the intervention group reached remission at 12 months, meaning HbA1c below 6.5% off all glucose-lowering medication. That result came from roughly 10 kg of weight loss on a continuous very-low-calorie formula diet. No fasting involved. If fasting helps a particular person lose 10 kg and keep it off, it’s contributing the way any diet would: through the deficit. Claims that fasting reverses diabetes are borrowing DiRECT’s result and swapping in a different intervention.

Key points

Most of the benefit tracks weight. Pavlou et al. (2023): HbA1c −0.91% vs −0.94% between an eating window and daily restriction, no difference.
The weight-independent signal is real but tiny: 8 men, 5 weeks, crossover (Sutton et al., 2018).
Fasting is non-inferior for HbA1c in type 2 diabetes: between-group difference 0.2 percentage points (Carter et al., 2018).
Hypoglycaemia risk is real in medicated type 2 diabetes: rate ratio 2.05 (95% CI 1.17 to 3.52) despite planned medication reduction (Corley et al., 2018).
Remission tracks the deficit, not the schedule: 46% at 12 months with about 10 kg of loss, on a non-fasting diet (Lean et al., 2018).

Common questions

Does intermittent fasting improve insulin sensitivity?

Mostly through weight loss, which any sustained calorie deficit produces. The evidence for improvement without weight loss is one 5-week crossover trial in 8 men with prediabetes (Sutton et al., 2018). Promising, small, unreplicated. If you’re fasting and losing weight, your insulin sensitivity is very likely improving, but the weight is doing the heavy lifting.

How long until fasting affects blood sugar?

In the 6-to-12-month trials, HbA1c fell by about 0.3 to 0.9 percentage points, a pace comparable to daily calorie restriction (Carter et al., 2018; Pavlou et al., 2023). HbA1c reflects roughly three months of glucose, so expect nothing meaningful on that measure inside a month. The deficit, not the schedule, sets the pace.

Is intermittent fasting safe with type 2 diabetes?

With clinician supervision and medication adjustment, the trials suggest it can be. Without supervision, no. Hypoglycaemia risk roughly doubled in medicated patients even with planned dose reductions (Corley et al., 2018). Insulin and sulfonylureas are the medications of most concern.

Can fasting reverse type 2 diabetes?

There’s no fasting-specific evidence for remission. The best remission result on record, 46% at 12 months, came from about 10 kg of weight loss on a continuous very-low-calorie diet (Lean et al., 2018). The deficit size mattered. The schedule wasn’t fasting.

Why does my blood sugar rise while I’m fasting?

Counter-regulatory hormones, cortisol and glucagon among them, can nudge glucose upward in the fasted state, especially in the morning. It’s common and usually small. A single reading isn’t a verdict; what a reading actually tells you makes the same argument for weight, and it holds for glucose too.

A note on safety

This is general information, not medical advice. If you take medication or have a health condition, talk to your clinician before changing when or what you eat. That goes double here: insulin and sulfonylureas carry real hypoglycaemia risk under fasting, medication that must be taken with food doesn’t pause because you did, and fasting isn’t appropriate in pregnancy, type 1 diabetes, or with a history of an eating disorder. The full list is its own article. Nothing above is dosing advice, and no lab value on its own is a verdict.

References

Sutton EF, et al. Early time-restricted feeding improves insulin sensitivity, blood pressure, and oxidative stress even without weight loss in men with prediabetes. Cell Metabolism. 2018;27(6):1212-1221.e3. doi:10.1016/j.cmet.2018.04.010
Wilkinson MJ, et al. Ten-hour time-restricted eating reduces weight, blood pressure, and atherogenic lipids in patients with metabolic syndrome. Cell Metabolism. 2020;31(1):92-104.e5. doi:10.1016/j.cmet.2019.11.004
Carter S, Clifton PM, Keogh JB. Effect of intermittent compared with continuous energy restricted diet on glycemic control in patients with type 2 diabetes: a randomized noninferiority trial. JAMA Network Open. 2018;1(3):e180756. doi:10.1001/jamanetworkopen.2018.0756
Corley BT, et al. Intermittent fasting in type 2 diabetes mellitus and the risk of hypoglycaemia: a randomized controlled trial. Diabetic Medicine. 2018;35(5):588-594. doi:10.1111/dme.13595
Lean MEJ, et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet. 2018;391(10120):541-551. doi:10.1016/S0140-6736(17)33102-1
Pavlou V, et al. Effect of time-restricted eating on weight loss in adults with type 2 diabetes: a randomized clinical trial. JAMA Network Open. 2023;6(10):e2339337. doi:10.1001/jamanetworkopen.2023.39337
Obermayer A, et al. Efficacy and safety of intermittent fasting in people with insulin-treated type 2 diabetes (INTERFAST-2): a randomized controlled trial. Diabetes Care. 2023;46(2):463-468.
Varady KA, et al. Clinical application of intermittent fasting for weight loss: progress and future directions. Nature Reviews Endocrinology. 2022;18(5):309-321. doi:10.1038/s41574-022-00638-x
Semnani-Azad Z, et al. Intermittent fasting strategies and their effects on body weight and other cardiometabolic risk factors: systematic review and network meta-analysis of randomised clinical trials. BMJ. 2025;389:e082007. doi:10.1136/bmj-2024-082007

remain.fit tracks a fasting window, weight and lab markers on one timeline, so you can see whether anything actually moved. The tools observe; the judging is left out.